CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.
Also called NCT06078215
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Registry
-
NCT06078215
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT06078215. Randomized; no masking; primary purpose treatment. Start 2023-01-10 (actual); primary completion 2025-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
- Acronym
- CERBERUS
- Condition
- Acute Ischemic Stroke
- Intervention (Combination product)
- Cerebrolysin
- Lead sponsor
- Poznan University of Medical Sciences
Record details
- Record id
cardio:ct-nct06078215- Content hash
1112ea84c9dd8bb3ea48f4221b94a86f26e798aa28d686157d866e6717261b87